55 related articles for article (PubMed ID: 22162108)
1. The protein synthesis inhibitors mycalamides A and E have limited susceptibility toward the drug efflux network.
Venturi V; Davies C; Singh AJ; Matthews JH; Bellows DS; Northcote PT; Keyzers RA; Teesdale-Spittle PH
J Biochem Mol Toxicol; 2012 Mar; 26(3):94-100. PubMed ID: 22162108
[TBL] [Abstract][Full Text] [Related]
2. The in vitro biological activities of synthetic 18-O-methyl mycalamide B, 10-epi-18-O-methyl mycalamide B and pederin.
Richter A; Kocienski P; Raubo P; Davies DE
Anticancer Drug Des; 1997 Apr; 12(3):217-27. PubMed ID: 9154112
[TBL] [Abstract][Full Text] [Related]
3. Change of ras-transformed NRK-cells back to normal morphology by mycalamides A and B, antitumor agents from a marine sponge.
Ogawara H; Higashi K; Uchino K; Perry NB
Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2152-4. PubMed ID: 1797440
[TBL] [Abstract][Full Text] [Related]
4. Isolation of swinholide A and related glycosylated derivatives from two field collections of marine cyanobacteria.
Andrianasolo EH; Gross H; Goeger D; Musafija-Girt M; McPhail K; Leal RM; Mooberry SL; Gerwick WH
Org Lett; 2005 Mar; 7(7):1375-8. PubMed ID: 15787510
[TBL] [Abstract][Full Text] [Related]
5. Total synthesis of (+)-mycalamide A.
Kagawa N; Ihara M; Toyota M
Org Lett; 2006 Mar; 8(5):875-8. PubMed ID: 16494463
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
Burres NS; Clement JJ
Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
[TBL] [Abstract][Full Text] [Related]
7. Mycalamides C and D, cytotoxic compounds from the marine sponge Stylinos n. species.
Simpson JS; Garson MJ; Blunt JW; Munro MH; Hooper JN
J Nat Prod; 2000 May; 63(5):704-6. PubMed ID: 10843596
[TBL] [Abstract][Full Text] [Related]
8. Onnamide F: a new nematocide from a southern Australian marine sponge, Trachycladus laevispirulifer.
Vuong D; Capon RJ; Lacey E; Gill JH; Heiland K; Friedel T
J Nat Prod; 2001 May; 64(5):640-2. PubMed ID: 11374963
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of fungal drug efflux transporters by heterologous expression in Saccharomyces cerevisiae.
Niimi M; Wada S; Tanabe K; Kaneko A; Takano Y; Umeyama T; Hanaoka N; Uehara Y; Lamping E; Niimi K; Tsao S; Holmes AR; Monk BC; Cannon RD
Jpn J Infect Dis; 2005 Feb; 58(1):1-7. PubMed ID: 15728981
[TBL] [Abstract][Full Text] [Related]
10. Isolation, biological activity, synthesis, and medicinal chemistry of the pederin/mycalamide family of natural products.
Mosey RA; Floreancig PE
Nat Prod Rep; 2012 Sep; 29(9):980-95. PubMed ID: 22772477
[TBL] [Abstract][Full Text] [Related]
11. Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans.
Chen CG; Yang YL; Tseng KY; Shih HI; Liou CH; Lin CC; Lo HJ
Fungal Genet Biol; 2009 Sep; 46(9):714-20. PubMed ID: 19527793
[TBL] [Abstract][Full Text] [Related]
12. Mycalamides, pederin and psymberin as natural carbohydrates and potential antitumor agents: past and future perspectives.
Witczak ZJ; Rampulla RM; Bommareddy A
Mini Rev Med Chem; 2012 Dec; 12(14):1520-32. PubMed ID: 22827176
[TBL] [Abstract][Full Text] [Related]
13. Acanthosterol sulfates A-J: ten new antifungal steroidal sulfates from a marine sponge Acanthodendrilla sp.
Tsukamoto S; Matsunaga S; Fusetani N; van Soest RW
J Nat Prod; 1998 Nov; 61(11):1374-8. PubMed ID: 9834155
[TBL] [Abstract][Full Text] [Related]
14. Total synthesis of mycalamide A.
Sohn JH; Waizumi N; Zhong HM; Rawal VH
J Am Chem Soc; 2005 May; 127(20):7290-1. PubMed ID: 15898759
[TBL] [Abstract][Full Text] [Related]
15. A stereoselective synthesis of the C-10 to C-18 (right-half) fragment of mycalamides employing lewis acid promoted intermolecular aldol reaction.
Toyota M; Hirota M; Hirano H; Ihara M
Org Lett; 2000 Jul; 2(14):2031-4. PubMed ID: 10891222
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis by the marine sponge (Mycale) metabolites, mycalamide A and pateamine.
Hood KA; West LM; Northcote PT; Berridge MV; Miller JH
Apoptosis; 2001 Jun; 6(3):207-19. PubMed ID: 11388670
[TBL] [Abstract][Full Text] [Related]
17. A formal synthesis of (-)-mycalamide A.
Trost BM; Yang H; Probst GD
J Am Chem Soc; 2004 Jan; 126(1):48-9. PubMed ID: 14709053
[TBL] [Abstract][Full Text] [Related]
18. Unique mechanism of action of an antifungal antibiotic RI-331.
Yamaki H; Yamaguchi M; Nishimura T; Shinoda T; Yamaguchi H
Drugs Exp Clin Res; 1988; 14(7):467-72. PubMed ID: 3071450
[TBL] [Abstract][Full Text] [Related]
19. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
Hasdemir U
Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
[TBL] [Abstract][Full Text] [Related]
20. Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry.
Pina-Vaz C; Rodrigues AG; Costa-de-Oliveira S; Ricardo E; Mårdh PA
J Antimicrob Chemother; 2005 Oct; 56(4):678-85. PubMed ID: 16115827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
